FDC falls on the bourses
FDC is currently trading at Rs. 489.95, down by 6.45 points or 1.30% from its previous closing of Rs. 496.40 on the BSE.
The scrip opened at Rs. 490.25 and has touched a high and low of Rs. 492.55 and Rs. 480.80 respectively. So far 7209 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 659.00 on 12-Sep-2024 and a 52 week low of Rs. 375.65 on 21-Dec-2023.
Last one week high and low of the scrip stood at Rs. 527.00 and Rs. 480.80 respectively. The current market cap of the company is Rs. 7961.41 crore.
The promoters holding in the company stood at 69.66%, while Institutions and Non-Institutions held 8.65% and 21.70% respectively.
FDC is recalling 1,55,232 bottles of Timolol Maleate ophthalmic solution in the US market. The company is recalling the affected lot due to ‘Defective Container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.’
The company initiated the Class II recall on October 29, 2024. Timolol Maleate ophthalmic solution is used to treat high pressure inside the eye due to glaucoma.
As per the U.S. Food and Drug Administration (USFDA), a Class II recall is initiated in a situation in which the use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.
FDC is among India’s leading fully integrated pharmaceutical companies.
